UltraSPECT Low-Dose Imaging Technology Installed at Four RWJPE Locations
Auburndale, Mass., July 14, 2016 – UltraSPECT Inc., a leading provider of image reconstruction solutions supporting safer and faster nuclear cardiology and oncology exams, today announced that Robert Wood Johnson Physician Enterprise (RWJPE), a multi-specialty, community-based physician group in Central New Jersey, implemented UltraSPECT’s Xpress3.Cardiac solution at four of their sites: Cardiology Associates of New Brunswick in New Brunswick, NJ; Heart Specialists of Edison in Edison, NJ; and New Brunswick Cardiology Group in their offices in Somerset, NJ and Monroe, NJ.
The software will benefit patient safety by reducing the dosage of injected radiopharmaceuticals, while lowering the radiation exposure for patients and nuclear staff alike. In addition, the technology saves valuable time for patients and staff, as it can produce the same high-quality SPECT images in less time than is typically required during standard exams.
“The image quality and clarity are remarkably good with UltraSPECT, which is particularly impressive when you consider that our scan time has been reduced by half in 80-90% of the cases,” said Jose Torres, Technology Director, New Brunswick Cardiology Group, Somerset, NJ. “UltraSPECT also helped us eliminate the two-day study protocol for heavier patients, who used to have to come back the next day for a stress test because the shorter scan times allow us to do more in the same visit. Patients are also more comfortable during the scan because they have to lay still for a shorter period of time.”
Torres also notes that the radiation exposure numbers on staff’s monthly dosimetry reports have been steadily going down after the UltraSPECT implementation. This is due to both reduced scan time and reduced doses needed for imaging tests.
All four installations are part of RWJPE’s radiopharmaceutical supply agreement with Nuclear Diagnostic Products (NDP). NDP delivers high-quality diagnostic and therapeutic radiopharmaceuticals to its customers and offers UltraSPECT products to facilities looking for a cost-effective solution to achieve faster and safer imaging while enhancing their diagnostic capabilities.
"Nuclear Diagnostic Products offers WBR software as part of its patient-centered approach to help the cardiovascular imaging community and patients by providing multi-vendor, cost-effective solutions to support safer imaging,” said Wayne Wong, owner and Vice President, NDP. “Our customers can now easily implement UltraSPECT’s software through the radiopharmaceutical supply agreement.”
At a fraction of the cost of a brand new camera, Xpress3.Cardiac™ provides value to physicians, technologists, patients, administrators and radiopharmaceutical suppliers and, together with Xpress.Cardiac™ and Xpress/Xact.Bone™, continues to be the most cost-effective dose-reduction solution in the nuclear medicine market. It significantly reduces injection doses, minimizing patient exposure to radiation, while simultaneously reducing scan times, delivering higher patient comfort and throughput. The resulting images are as good, if not better in diagnostic quality, than those provided with traditional SPECT acquisition and enable high diagnostic confidence. All UltraSPECT solutions are compatible with 41 different gamma cameras and 12 workstations representing all the major manufacturers.
UltraSPECT has been providing image reconstruction solutions supporting safer and faster nuclear cardiology and oncology exams since 2006. It has 450 installations in over 300 health systems across the U.S., including St. Luke’s-Roosevelt Hospital in New York City, Mayo Clinic in Rochester, MN, Duke University Medical Center in Durham, NC, Henry Ford Wyandotte Hospital in Wyandotte, Mich., and multiple MaineHealth facilities throughout the state.
For more information about the UltraSPECT technologies and reducing dose in nuclear medicine, visit www.ultraspect.com or call 1-888-WBR-SCAN(1-888-927-7226).